IVERIC bio: Funding, Investors & Team (Oct 2026)
IVERIC bio is a science-driven biopharmaceutical organization zeroed in on the revelation and improvement of novel therapy choices for retinal sicknesses with critical neglected clinical requirements. The Company is at present creating both helpful item possibility for age-related retinal illnesses and quality treatment item contender for vagrant acquired retinal sicknesses.
IVERIC bio has raised $250M across 1 funding round on record, the most recent a Post-IPO Debt of $250M announced in Jul 2022.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
IVERIC bio Company Profile and Key Stats
Latest funding round on record: Jul 2022.
IVERIC bio Funding Rounds
IVERIC bio Founders and Leadership Team
Contact details for the IVERIC bio team: 1 of 1 has an email address on file.
Start 14-day free trial →IVERIC bio Funding Compared to Other Biotechnology Startups
IVERIC bio's latest round of $250M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like IVERIC bio in Biotechnology and Princeton
Companies Similar to IVERIC bio
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
IVERIC bio Funding FAQs
What does IVERIC bio do?
IVERIC bio is a science-driven biopharmaceutical organization zeroed in on the revelation and improvement of novel therapy choices for retinal sicknesses with critical neglected clinical requirements. The Company is at present creating both helpful item possibility for age-related retinal illnesses and quality treatment item contender for vagrant acquired retinal sicknesses.
How much funding has IVERIC bio raised?
IVERIC bio has raised $250M across 1 round on record. The most recent is a Post-IPO Debt of $250M announced in Jul 2022.
When did IVERIC bio last raise funding?
IVERIC bio's most recent funding round on record is a Post-IPO Debt of $250M, announced in Jul 2022.
Who is the CEO of IVERIC bio?
Glenn Sblendorio is listed as CEO at IVERIC bio.
Where is IVERIC bio headquartered?
IVERIC bio is based in Princeton, New Jersey, United States.
How many employees does IVERIC bio have?
IVERIC bio is in the 51-100 employee band.
How does IVERIC bio's funding compare to other Biotechnology startups?
IVERIC bio's latest round of $250M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's IVERIC bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for IVERIC bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.